References in periodicals archive ?
First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS) Health Technol Assess 2003;7: 1-77.
[4] Nonstandard abbreviations: PAPP-A, pregnancy-associated plasma protein A; hCG[beta], [beta]-subunit human chorionic gonadotropin; MoM, multiple of median; DBS, dried blood spot; SURUSS, Serum Urine and Ultrasound Screening Study; EQA, external quality assessment.
First and second trimester antenatal serum screening for Down's syndrome: The results of the SURUSS Study.
In SURUSS, which enrolled 47,000 women, the integrated test had a 93% detection rate with a 5% false-positive rate.
The footnotes for the tables, however, were not updated when we analyzed the results using the SURUSS parameters (4, 5).
In contrast, the larger SURUSS study (13) reported that detection ranged from a low of 16% at 11 weeks of gestation to a high of 43% at 13 weeks of gestation.
First and second trimester antenatal screening for Down's syndrome: the results from the Serum, Urine, and Ultrasound Screening Study (SURUSS).
Urine ITA was also analyzed as part of the Serum, Urine, and Ultrasound Screening Study (SURUSS) in 2003 and was reported to detect 40% of second-trimester Down syndrome pregnancies (10).
(39.) Wald NJ, Rodeck C, Hackshaw AK, Waiters J, Chitty L, Mackinson AM; SURUSS Research Group.